Investigation on environmental factors contributing to bispecific antibody stability and the reversal of self-associated aggregates
Bispecific antibodies (bsAbs) hold promises for enhanced therapeutic potential surpassing that of their parental monoclonal antibodies. However, bsAbs pose great challenges in their manufacturing, and one of the common reasons is their susceptibility to aggregation. Building on previous studies demonstrating the functionality and potential manufacturability of Fab-scFv format bsAb, this investigation delved into the impact of environmental factors-such as pH, buffer types, ionic strength, protein concentrations, and temperatures-on its stability and the reversal of its self-associated aggregates. Mildly acidic, low-salt conditions were found optimal, ensuring bsAb stability for 30 days even at elevated temperature of 40 °C. Furthermore, these conditions facilitated the reversal of its self-associated aggregates to monomers during the initial 7-day incubation period. Our findings underscore the robustness and resilience of Fab-scFv format bsAb, further confirming its potential manufacturability despite its current absence as commercial products.
Authors
- Yuansheng Yang (ORCID: https://orcid.org/0000-0002-0026-7069)
- Nattha Ingavat
- Say Kong Ng (ORCID: https://orcid.org/0000-0002-4196-2754)
- Jia Min Liew
- Han Ping Loh (ORCID: https://orcid.org/0000-0003-1972-0190)
- Wei Zhang (ORCID: https://orcid.org/0000-0001-8597-5357)
- Eunice S. P. Leong (ORCID: https://orcid.org/0000-0002-4895-4044)
- Nuruljannah Dzulkiflie
- Xinhui Wang
Institutions
- Agency for Science, Technology and Research (SG)
- Bioprocessing Technology Institute (SG)
Publication Details
- Journal
- Bioresources and Bioprocessing
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1186/s40643-024-00796-y
- Citations
- 7
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 2.83
Funders
- Agency for Science, Technology and Research
- Biomedical Research Council